UNLIMITED TURBO LONG - TANDEM DIABETES CARE Share Price

Certificat

DE000PC9XY37

Market Closed - Bid/Ask 20:50:38 28/06/2024 BST
0.63 EUR -4.55% Intraday chart for UNLIMITED TURBO LONG - TANDEM DIABETES CARE
Current month-62.05%
1 month-65.00%
Date Price Change
28/06/24 0.63 -4.55%
27/06/24 0.66 0.00%
26/06/24 0.66 +6.45%
25/06/24 0.62 +12.73%
24/06/24 0.55 -36.05%

Real-time Boerse Frankfurt Warrants

Last update June 28, 2024 at 08:50 pm

More quotes

Static data

Product typeKnock-Out ohne Stop Loss
Buy / SellCALL
Underlying TANDEM DIABETES CARE, INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC9XY3
ISINDE000PC9XY37
Date issued 16/05/2024
Strike 35.39 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.93
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 1.86
Lowest since issue 0.55
Spread 0.02
Spread %3.03%

Company Profile

Tandem Diabetes Care, Inc. is a global insulin delivery and diabetes technology company, which manufactures and sells advanced automated insulin delivery systems. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of it AID systems, it offers pump integration with multiple CGM sensors.
Sector
-
More about the company

Ratings for Tandem Diabetes Care, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Tandem Diabetes Care, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
40.43 USD
Average target price
49.93 USD
Spread / Average Target
+23.51%
Consensus